Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

BACKGROUND: Early phase malaria vaccine field trials typically measure malaria infection by PCR or thick blood smear microscopy performed on serially sampled blood. Vaccine efficacy (VE) is the proportion reduction in an endpoint due to vaccination and is often calculated as [Formula: see text] – ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, Gail E., Callier, Viviane, Shrestha, Biraj, Joshi, Sudhaunshu, Dwivedi, Ankit, Silva, Joana C., Laurens, Matthew B., Follmann, Dean A., Deye, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543529/
https://www.ncbi.nlm.nih.gov/pubmed/37790581
http://dx.doi.org/10.21203/rs.3.rs-3370731/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543529/
https://www.ncbi.nlm.nih.gov/pubmed/37790581
http://dx.doi.org/10.21203/rs.3.rs-3370731/v1

Ejemplares similares